<DOC>
	<DOCNO>NCT00666107</DOCNO>
	<brief_summary>This study investigate efficacy safety quadrivalent vaccine ( Gardasil ) human papilloma virus ( HPV ) HIV ( human immunodeficiency virus ) infect male .</brief_summary>
	<brief_title>Pilot Study Determine Safety Efficacy Gardasil Against Human Papilloma Virus ( HPV ) HIV-infected Men</brief_title>
	<detailed_description>This prospective pilot study attempt enroll approximately 150-200 HIV-infected male follow regularly ID Primary Care Clinic VA Long Beach Healthcare System . All consent patient give HPV vaccine ( Gardasil ) three intramuscular injection . Baseline antibody titer HPV strain 16 18 obtain day 0 repeat level obtain approximately 8 week completion vaccination series determine whether patient without antibody baseline produce antibody , determine change antibody level patient evidence antibody prior first injection vaccine . Patients undergo routine anal PAP smear HPV DNA test baseline another PAP smear/HPV test approximately 8 week completion series . Patients report side effect vaccine PI . Patients blood work monitor HIV-1 viral load CD4 lymphocytes count various point study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male veteran Age 18 old HIVpositive Seen regularly ID Primary Care Clinic VA Long Beach Healthcare System</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>HPV</keyword>
	<keyword>HIV</keyword>
	<keyword>Gardasil</keyword>
	<keyword>Vaccine</keyword>
</DOC>